1. CBF and cognitive evaluation of Alzheimer type patients before and after IMAO-B treatment: a pilot study;Agnoli;Eur. Neuropsychopharmacol.,1992
2. Associations between vascular function and tau PET are associated with global cognition and amyloid;Albrecht;J. Neurosci.,2020
3. The problem of aducanumab for the treatment of Alzheimer disease;Alexander;Ann. Intern. Med.,2021
4. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer’s disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion;Álvarez;Methods Find. Exp. Clin. Pharm.,1999
5. Álvarez, X., Pichel, V., Pérez, P., Laredo, M., Corzo, D., Zas, R., et al., 2000. Double-Blind, Random, Place. -Control. Pilot Study anapsos Sen. Dement.: Eff. Cogn., brain bioelectrical Act. Cereb. hemodynamics, pp. 585–594.